Chuyue Zhang

Chuyue Zhang

Auto-generated profile, based on publicly available information

Chuyue Zhang

Laboratory of Cancer Biology, Department of Oncology, University of Oxford, Oxford, UK

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 August 2026 in EMBO Molecular Medicine
Verified
Journal Article
Open access
PDF file
WBWiktoria Blaszczak
Wiktoria Blaszczak
WBWojciech Barczak
Wojciech Barczak
CZChuyue Zhang
Chuyue Zhang
GRGarret Rochford
Garret Rochford
ANAnnalisa Nicastri
Annalisa Nicastri
NTNicholas B La Thangue
Nicholas B La Thangue
PRMT5 is expressed at high levels in many cancers, where it regulates diverse cellular pathways that contribute to oncogenesis. Here, we have defined a new role for PRMT5 in regulating and coordinating the interplay between the innate and adaptive immune response. This occurs, in part, through the influence of PRMT5 and E2F1 on RNA splicing and the presence of retained introns (RIs). We found that RIs have a propensity to form double-stranded RNAs that contribute to the innate response. Furthermore, many RIs contain non-canonical open-reading frames (ncORFs), which can be translated and then processed into small peptides that assemble with the MHC class I complex. Significantly, RI-derived peptides are highly immunogenic and, as a murine cancer vaccine, carrying a string of antigenic RI peptides, delayed tumour growth and enhanced survival. RIs are present in human tumour cells, and we identified T lymphocytes in human cancer patients, with antigen specificity for RI-derived peptides, that killed human tumour cells in vitro. Regulating intron retention thus offers a new therapeutic approach to enhance tumour immunogenicity.